跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HANZEMA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HANZEMA
Authorized
STANDARD
HANZEMA
DR. REDDY'S LABORATORIES, INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
faa1058c1d1f819b
Company
DR. REDDY'S LABORATORIES, INC.
Type
Standard
Approval Details
Approval Id
faa1058c1d1f819b
Drug Approval Canada Name
HANZEMA
Product Name
HANZEMA
Status
Marketed
Status Date
2021-06-09
Original Market Date
2021-06-09
Din
02477440
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
84:92.00
Atc Original
D11AH04 ALITRETINOIN
Atc Name
d 11 ah 04
Aig Number
0137581003
Company Name
DR. REDDY'S LABORATORIES, INC.
Company Address
SUITE 4000 4TH FLOOR, 600 College Road East, Princeton, New Jersey, United States, 08540
Company Detail Path
/organization/dr-reddys-laboratories-inc
Company Information
Pharmaceutical Company Name
DR. REDDY'S LABORATORIES, INC.
Country Name
United States
Province Name
北卡罗来纳州
City Name
北卡罗来纳州梅克伦堡县
Address
200 Somerset Corporate Blvd FL 7
Website
http://www.drreddys.com
Active Ingredients
ALITRETINOIN
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
faa1058c1d1f819b
Type
Standard
Back to Health Canada Approvals